Martine A Rothblatt, Chairperson & CEO at UNITED THERAPEUTICS, sold UTHR on Jun 25, 2026
Data as of Oct 16
- Traded
- Jun 25, 2026
- Disclosed
- Jun 26, 2026
- Filed
- 1 day after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
UTHR since disclosure
−1.8%
after the sale
Similar stocks (XLV) since disclosure
+10.2%
XLV — its sector index fund
Change in closing price from Jun 26, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$133Kdisclosed Jun 26 · filed 1 day after the trade
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$354Kdisclosed Jun 26 · filed 1 day after the trade
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$164Kdisclosed Jun 26 · filed 1 day after the trade
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$1Mdisclosed Jun 26 · filed 1 day after the trade
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$372Kdisclosed Jun 26 · filed 1 day after the trade
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$242Kdisclosed Jun 26 · filed 1 day after the trade
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$983Kdisclosed Jun 26 · filed 1 day after the trade
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$419Kdisclosed Jun 26 · filed 1 day after the trade
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$228Kdisclosed Jun 26 · filed 1 day after the trade
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$891Kdisclosed Jun 26 · filed 1 day after the trade